Skip to content

Regeneron Pharmaceuticals REGN Total Operating Expenses

Total Operating Expenses at other companies

Glaukos logo
GlaukosGKOS
$137.09M+33.1%
EyePoint, Inc.
 logo
EyePoint, Inc. EYPT
$87.92M+20.0%
Precigen logo
PrecigenPGEN
$29.25M+22.2%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$59.78M+1.2%
Annexon logo
AnnexonANNX
$46.05M-19.8%
4D Molecular Therapeutics logo
4D Molecular TherapeuticsFDMT
$76.67M+42.9%

Other financials

Income statement

See full
Revenue$3.6B+19.0%
Operating income$642.9M+8.7%
Net income$727.2M-10.1%
EPS (diluted)$6.75-7.2%

Balance sheet

See full
Cash & equivalents$3.0B-4.0%
Total debt$2.7B+0.1%
Total equity$31.4B+6.9%
Total assets$40.9B+8.9%

Cash flow

See full
Operating cash flow$1.1B+3.2%
CapEx$230.6M+0.6%
Free cash flow$848.3M+4.0%

Valuation

See full
Market cap$68.78B+14.0%
Enterprise value$68.51B+12.3%
P/E15.6×+2.0×
P/S4.6×+0.4×

Profitability

See full
Gross margin93.9%
Operating margin24.3%-2.9pp
Net margin29.6%-2.3pp
FCF margin27.6%+5.5pp

Returns & leverage

See full
Return on equity14.5%-1.4pp
Debt / equity0.1×0.0×
Current ratio3.6×-1.4×

Questions, answered.

What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.